期刊文献+

慢性肾脏病矿物质-骨代谢异常非侵入性检查进展 被引量:3

原文传递
导出
摘要 近年来,慢性肾脏病矿物质-骨代谢异常(chronic kidney disease-mineral and bone disorder,CKD-MBD)越来越受到肾脏界所重视,其诊治方法也在不断更新,骨组织学活检及血管病理学检查虽然是CKD患者骨病和血管钙化的诊断金标准,但是其只能反映某一时间点骨代谢及血管钙化的情况,不能反映一个持续性变化.同时,组织活检作为一种侵入性检查,临床上不能被多数患者所接受,从而给CKD-MBD的早期诊断带来困难.因此,寻求一些非侵入性或非创伤性检查来早期诊断CKD-MBD尤其重要.本文就CKD-MBD早期诊断的血清学标记物及影像学检查相关进展作一综述.
作者 李健 陈卫东
出处 《国际泌尿系统杂志》 2014年第5期764-769,共6页 International Journal of Urology and Nephrology
  • 相关文献

参考文献42

  • 1Matuszkiewicz-Rowi(n)ska J.KDIGO clinical practice guidelines for the diagnosis,evaluation,prevention,and treatment of mineral and bone disorders in chronic kidney disease[J].Pal Arch Med Wewn,2010,120(7-8):300-306.
  • 2Moe SM,Drüeke TB,Block GA,et al.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)[J].Kidney Int Suppl Aug,2009,113:S1-S130.
  • 3Barreto FC,Barreto DV,Moyses RM,et al.K/DOQIrecommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients[J].Kidney Int,2008,73 (6):771-777.
  • 4Faugere Mc,Gao P,Geng Z,et al.The 1-84:7-84 ratio for determination of bone turnover in chronically dialized patients(Abstract)[J].J Am Soc Nephrol,2000,11:554A.
  • 5O'Flaherty,D,Sankaralingam A,Scully P,et al.The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease(CKD)[J].Clin Biochem,2013,46(15):1405-1409.
  • 6Rodriguez M,Lorenzo V.Parathyroid hormone,a uremic toxin[J].Semin Dial,2009,22 (4):363-368.
  • 7Coen G,Ballanti P,Bonueei E,el al.Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients[J].Nephrol Dial Transplant,1998,13 (9):2294.
  • 8Park JC,Kovesdy CP,Duong U,et al.Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients[J].Hemodial Int,2010,14 (2):182-192.
  • 9Terkeltaub RA.Inorganic pyrophosphate generation and disposition in pathophysiology[J].Am J Physiol Cell Physiol,2001,281 (1):C1-C11.
  • 10Riser BL,Barreto FC,Rezg R,et al.Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mousemodel of uraemia[J].Nephrol Dial Transplant,2011,26(10):3349-3357.

同被引文献33

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部